194 related articles for article (PubMed ID: 18292550)
1. Regulation of the NK cell alloreactivity to bone marrow cells by the combination of the host NK gene complex and MHC haplotypes.
Iizuka K; Scalzo AA; Xian H; Yokoyama WM
J Immunol; 2008 Mar; 180(5):3260-7. PubMed ID: 18292550
[TBL] [Abstract][Full Text] [Related]
2. NK cell tolerance in mixed allogeneic chimeras.
Zhao Y; Ohdan H; Manilay JO; Sykes M
J Immunol; 2003 Jun; 170(11):5398-405. PubMed ID: 12759414
[TBL] [Abstract][Full Text] [Related]
3. Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants.
Liu J; Morris MA; Nguyen P; George TC; Koulich E; Lai WC; Schatzle JD; Kumar V; Bennett M
J Immunol; 2000 Feb; 164(4):1793-9. PubMed ID: 10657626
[TBL] [Abstract][Full Text] [Related]
4. Tolerance and alloreactivity of the Ly49D subset of murine NK cells.
George TC; Ortaldo JR; Lemieux S; Kumar V; Bennett M
J Immunol; 1999 Aug; 163(4):1859-67. PubMed ID: 10438920
[TBL] [Abstract][Full Text] [Related]
5. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation.
Wang JW; Howson JM; Ghansah T; Desponts C; Ninos JM; May SL; Nguyen KH; Toyama-Sorimachi N; Kerr WG
Science; 2002 Mar; 295(5562):2094-7. PubMed ID: 11896280
[TBL] [Abstract][Full Text] [Related]
6. Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing.
Sun K; Alvarez M; Ames E; Barao I; Chen M; Longo DL; Redelman D; Murphy WJ
Blood; 2012 Feb; 119(6):1590-8. PubMed ID: 22184406
[TBL] [Abstract][Full Text] [Related]
7. The NK2.1 receptor is encoded by Ly-49C and its expression is regulated by MHC class I alleles.
Gosselin P; Lusignan Y; Brennan J; Takei F; Lemieux S
Int Immunol; 1997 Apr; 9(4):533-40. PubMed ID: 9138013
[TBL] [Abstract][Full Text] [Related]
8. Genetic investigation of MHC-independent missing-self recognition by mouse NK cells using an in vivo bone marrow transplantation model.
Chen P; Aguilar OA; Rahim MM; Allan DS; Fine JH; Kirkham CL; Ma J; Tanaka M; Tu MM; Wight A; Kartsogiannis V; Gillespie MT; Makrigiannis AP; Carlyle JR
J Immunol; 2015 Mar; 194(6):2909-18. PubMed ID: 25681346
[TBL] [Abstract][Full Text] [Related]
9. NK cells rapidly reject allogeneic bone marrow in the spleen through a perforin- and Ly49D-dependent, but NKG2D-independent mechanism.
Hamby K; Trexler A; Pearson TC; Larsen CP; Rigby MR; Kean LS
Am J Transplant; 2007 Aug; 7(8):1884-96. PubMed ID: 17617852
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of Ly-49 receptors on NK cells developing in mixed allogeneic bone marrow chimeras.
Manilay JO; Waneck GL; Sykes M
Int Immunol; 1998 Dec; 10(12):1943-55. PubMed ID: 9885916
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts.
Raziuddin A; Bennett M; Winkler-Pickett R; Ortaldo JR; Longo DL; Murphy WJ
Blood; 2000 Jun; 95(12):3840-4. PubMed ID: 10845918
[TBL] [Abstract][Full Text] [Related]
13. Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice.
Raziuddin A; Longo DL; Mason L; Ortaldo JR; Murphy WJ
Int Immunol; 1996 Dec; 8(12):1833-9. PubMed ID: 8982767
[TBL] [Abstract][Full Text] [Related]
14. An autosomal dominant locus, Nka, mapping to the Ly-49 region of a rat natural killer (NK) gene complex, controls NK cell lysis of allogeneic lymphocytes.
Dissen E; Ryan JC; Seaman WE; Fossum S
J Exp Med; 1996 May; 183(5):2197-207. PubMed ID: 8642329
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
[TBL] [Abstract][Full Text] [Related]
16. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.
Held W; Cado D; Raulet DH
J Exp Med; 1996 Nov; 184(5):2037-41. PubMed ID: 8920892
[TBL] [Abstract][Full Text] [Related]
17. Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens.
Raziuddin A; Longo DL; Bennett M; Winkler-Pickett R; Ortaldo JR; Murphy WJ
Blood; 2002 Oct; 100(8):3026-33. PubMed ID: 12351417
[TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility complex genes determine natural killer cell tolerance.
Dorfman JR; Raulet DH
Eur J Immunol; 1996 Jan; 26(1):151-5. PubMed ID: 8566058
[TBL] [Abstract][Full Text] [Related]
19. Ly-49s3 is a promiscuous activating rat NK cell receptor for nonclassical MHC class I-encoded target ligands.
Naper C; Hayashi S; Kveberg L; Niemi EC; Lanier LL; Vaage JT; Ryan JC
J Immunol; 2002 Jul; 169(1):22-30. PubMed ID: 12077224
[TBL] [Abstract][Full Text] [Related]
20. Genetic control of natural killing and in vivo tumor elimination by the Chok locus.
Idris AH; Iizuka K; Smith HR; Scalzo AA; Yokoyama WM
J Exp Med; 1998 Dec; 188(12):2243-56. PubMed ID: 9858511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]